![]() |
|||||||||||||||||||||||||
|
Partners
Medical Imaging Business
PharmaAsia is the leading source of information for scientists in Asia looking to stay abreast of innovative technologies and trends impacting the pharmaceutical industry. Published in English, PharmaAsia reaches 10,000* qualified readers across the region. For more information, please visit www.pharmaasia.com. Biomarkers in Medicine is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. For more information please see http://www.futuremedicine.com/loi/bmm Future Oncology takes a forward-looking stance toward scientific and clinical issues, together with the economic and policy issues, that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. For more information please see http://www.futuremedicine.com/loi/fon Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. For more information please see http://www.futuremedicine.com/loi/pgs
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. For more information please see http://www.futuremedicine.com/loi/pme Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. All articles are subject to rigorous peer-review. For more information please visit http://www.expert-reviews.com/loi/era
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market.
Drug Discovery Today is a review journal, published as 12 monthly double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields and cover all aspects of drug discovery from state-of-the-art genomic and proteomic approaches to target identification, through the most innovative computational approaches to drug design, the science driving medicinal chemistry and the translation of these sciences to therapies. Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting in- and out-licensing activities, Pharmalicensing provides partnering services, business development reports, industry news and a jobs source for candidates and employers.
Pharmalicensing is used by over 90,000 users per month and is a division of UTEK Corporation. Visit www.pharmalicensing.com
Asia Pacific Biotech News (APBN), published by World Scientific Publishing, is Asia Pacific's leading authority on the life science industry, discussing scientific and business issues every month in the life sciences industry. APBN offers the latest news updates, new product releases
Cancer Investigation delivers the latest translational cancer research discoveries that bridge the gap between the laboratory and the clinic. Under the expert leadership of Dr. Gary Lyman and his distinguished editorial board, Cancer Investigation is now focused to better represent the revolution in our understanding of cancer and its management.
BioCentury's mission is to provide value-added information and analysis for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, emerging technology, clinical data, public policy and the financing markets.
KONGPOSH Publications is one of the leading publishers of pharma journals in India and publish the THE PHARMA REVIEW referred to as "The UMBRELLA JOURNAL OF THE INDIAN PHARMA INDUSTRY".
Sino-American Biotechnology and Pharmaceutical Professional Association (SABPA) is an 501(c)(3) non-profit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA. ©Copyright Phacilitate Limited 2008
|
» Click here to suggest a speaker or to contribute to the agendas » Click here to review the Oncology Leaders' Forum Agenda outline » Click here to review the R&D Leaders' Forum Agenda outline
|
|||||||||||||||||||||||